Company / Operating Cash Flow per Share
ANAPTYSBIO, INC Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$0.65
FY2025
5-year range
-$5.09 / $0.65
FY2021-FY2025
Trend
+112.7%
vs FY2024
Sector context
#63 of 212
Health Care
What the data says
At $0.65, ANAPTYSBIO, INC's operating cash flow per share ranks #63 of 212 in the Health Care sector. Operating Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $0.65.
Based on SEC 10-K filings.
0.65 in FY2025.
Improved from $-4.24 to $0.65 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#63 of 212 in Health CareTop 30% of 212This company $0.65 Sector average -$14.72
▼
+104.4% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 112.7% year-over-year.
- Ranks #63 out of 212 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.65 | +112.7% |
| FY2024 | -$5.09 | -20.1% |
| FY2023 | -$4.24 | -727.4% |
| FY2022 | -$0.51 | +79.8% |
| FY2021 | -$2.54 | -42.8% |
| FY2020 | -$1.78 | -146.5% |
| FY2019 | -$0.72 | +63.3% |
| FY2018 | -$1.97 | +46.2% |
| FY2017 | -$3.66 | -6.8% |
| FY2016 | -$3.42 | +9.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026